Assistant Professor and Oncofertility Program Director, Reproductive Endocrinology and Infertility
- M.D. University of Khartoum
- M.M.S. University of Texas Medical Branch
The focus of my lab is to promote fertility and reproductive health preservation in female cancer patients. Female cancer survivors are at increased risk of ovarian insufficiency, which predispose them to infertility, osteoporosis, heart disease and psychological distress. My lab is developing novel drug-based therapy for ovarian protection from chemotherapy toxicity. It is hoped that these drugs will allow many cancer survivors to enjoy both a cancer-free life with full reproductive and sexual health. Drug-based ovarian shields is expected to close the socioeconomic gap in fertility preservation in cancer patients by being a cost-effective, easy to administer, and affordable.
Highlights in your Career
Membership of Royal College of Obstetrics and Gynecology, United Kingdom.
Residency in Obstetrics and Gynecology, Yale University.
Fellowship in Human Molecular Genetics, Yale University.
Fellowship in Reproductive Endocrinology and Infertility, University of Texas Medical Branch.
Oncofertility Program Director, University of Wisconsin.
I love to travel and meet people and listen to local jokes. I love to cook and I enjoy spending time with my family.
What have you gained from your experience as a BIRCWH/T32 Scholar?
Being a BIRCWH scholar, I was exposed to outstanding mentors that genuinely cared about my career development, both in research and in the clinic. I learned research is fun and “doable”. I learned to go out of my way to help others accomplish their full potential. I made ever-lasting connections that I will cherish throughout the remainder of my life. I am ready to pass on my knowledge and experience to aspiring scientists.